• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Redsense Clamp CE marked and introduced across key markets

REDSRegulatory press release12.08.2025, 16.08
Download the release

Redsense Medical is pleased to announce that the clamp is CE marked and has been introduced in the UK, Canadian, and German markets. We have been working closely with our distribution partners and dialysis providers, with the first demonstrations performed and pilot study discussions started.

"Being able to place the CE mark on our device was a defining moment, but the real progress is happening now as we work alongside our partners and clinical contacts to ensure a smooth introduction," said Sebastien Bollue, CEO at Redsense Medical. "We're also developing optimised visuals, marketing materials, and instruction videos in applicable languages to support both providers and patients in adopting the device."

The Clamp is currently available through authorized partners in the UK and Canada, while in Germany the first efforts have been made directly. Prior distribution partners in other EU markets have also been approached, while additional translations may be required as a next step to support these opportunities.